AIMC Topic: Cell Line, Tumor

Clear Filters Showing 41 to 50 of 628 articles

GLA-Synergy: An Interpretable Global-Local Adaptive Framework for Drug Synergy Prediction in Cancer Treatment.

Journal of chemical information and modeling
Effective anticancer drug combinations are crucial for advancing cancer treatment, yet predicting drug synergy remains challenging due to the complexity of biological interactions. Existing methods struggle to integrate multimodal features and to mod...

Single-cell and spatial transcriptomics reveal post-translational modifications in osteosarcoma progression and tumor microenvironment.

PloS one
Emerging evidence suggests that post-translational modifications (PTMs) contribute to osteosarcoma pathogenesis, yet their exact molecular roles require further elucidation. Using the AddModuleScore method, we classified tumor cells on the basis of P...

Multi-omics identification of RNASE6 as an immune regulatory RNA-binding protein associated with melanoma metastasis.

Autoimmunity
BACKGROUND: Cutaneous melanoma is a highly invasive tumor. It enhances metastasis and resistance to immunotherapy immunosuppressive mechanisms. Understanding RNA-binding proteins (RBPs) in melanoma's immune alterations is limited. This study explore...

HCS-3DX, a next-generation AI-driven automated 3D-oid high-content screening system.

Nature communications
Self-organised three-dimensional (3D) cell cultures, collectively called 3D-oids, include spheroids, organoids and other co-culture models. Systematic evaluation of these models forms a critical new generation of high-content screening (HCS) systems ...

Identification of methylation-related genes and the potential regulatory mechanism of SLAMF6 in CMS4 colorectal cancer.

Clinical epigenetics
BACKGROUNDS: Consensus molecular subtype 4 (CMS4) of colorectal cancer (CRC) is characterized by TGF-β activation, and generally accompanied with metastasis and recurrence. Nevertheless, molecular biomarkers and regulatory mechanisms underlying CMS4 ...

BLVRA promotes glioblastoma progression by regulating fatty acid metabolism.

Scientific reports
Fatty acid metabolism is critically involved in glioblastoma (GBM) pathogenesis; however, its regulatory mechanisms remain incompletely understood. In this study, we identified biliverdin reductase A (BLVRA) as a novel metabolic driver and prognostic...

Identification of a novel Aurora B inhibitor using the AI-driven drug screening and docking-based traditional screening.

Bioorganic & medicinal chemistry
Aurora B, a subtype of Aurora kinases that functions as a serine/threonine kinase, playing a vital role in the process of mitosis, is often overexpressed in certain tumor cells leading to tumorigenesis and progression. Therefore, the development of s...

Single-Cell Raman Spectroscopy Combined with Metabolomics Reveals Distinct Metabolic Profiles in Medulloblastoma Subtypes.

Analytical chemistry
Tumor heterogeneity poses a major challenge to the precision treatment of medulloblastoma (MB). Rapid and accurate subtyping tools are urgently needed for informed clinical decision-making. Herein, we demonstrate the utility of Raman spectroscopy (RS...

An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer.

Nature communications
Pancreatic cancer is an aggressive disease with a dense fibrotic stroma and is often accompanied by chronic inflammation. Peritumoral inflammation is typically viewed as a reaction to nearby tumor growth. Here, we report that the inflamed pancreatic ...